Contents
Step 2 CK and the shelf exams test the same disease from two angles. "What is the most appropriate next step in diagnosis?" usually wants the first, cheapest or most sensitive test. "Which test is most likely to confirm the diagnosis?" wants the most accurate one. Many wrong answers are the right test at the wrong moment, so read the verb in the question before you read the options.
The approach: which test the question wants
- Read the lead-in"Next step" or "initial" means the first test in the sequence. "Most accurate," "confirm" or "definitive" means the reference standard.
- Check stabilityAn unstable patient gets the bedside test: echocardiography for suspected massive PE, TEE for suspected aortic dissection, ultrasound in trauma. Do not send a crashing patient to the scanner.
- Weigh pretest probabilityA sensitive test such as D-dimer rules a diagnosis out only when the probability is already low. High probability skips straight to imaging.
- Screen with a sensitive test, confirm with a specific oneThe adrenal disorders follow this pattern: a screening hormone test, then a confirmatory test, and only then imaging.
- Prefer the noninvasive confirmation when it existsTypical HCC on multiphase imaging needs no biopsy; a low 4Ts score needs no HIT assay.
The pairs
| Condition | Initial test | Best or confirmatory test | The detail that gets tested |
|---|---|---|---|
| Pulmonary embolism, stable | Clinical probability (Wells or Geneva); D-dimer only if probability is low or intermediate | CT pulmonary angiography | V/Q scan if contrast is contraindicated; unstable patient gets bedside echocardiography |
| Acute aortic dissection | CT angiography in a stable patient | CT angiography; TEE if unstable | A normal chest radiograph does not exclude it |
| Infective endocarditis | Three sets of blood cultures before antibiotics, and transthoracic echocardiography | Transesophageal echocardiography | Go straight to TEE with a prosthetic valve or when TTE is negative and suspicion stays high |
| Heparin-induced thrombocytopenia | 4Ts score | Anti-PF4/heparin immunoassay, then a functional assay such as the serotonin release assay | Low 4Ts score: no testing and no empiric treatment |
| Celiac disease | Tissue transglutaminase IgA with total IgA, on a gluten-containing diet | Duodenal biopsy | IgA deficiency gives a false-negative tTG-IgA; use deamidated gliadin IgG |
| H. pylori | Urea breath test or stool antigen | Biopsy-based testing when endoscopy is indicated | Serology cannot show active infection or confirm eradication |
| Pheochromocytoma | Plasma free or urine fractionated metanephrines | CT or MRI of the abdomen after biochemical confirmation | Imaging first finds incidentalomas, not answers |
| Primary aldosteronism | Plasma aldosterone to renin ratio | Confirmatory suppression test, then adrenal CT, then adrenal vein sampling before surgery | Spontaneous hypokalemia, undetectable renin and aldosterone above 20 ng/dL make confirmation unnecessary |
| Cushing syndrome | 1 mg overnight dexamethasone test, late-night salivary cortisol or 24-hour urine free cortisol | A second abnormal test from that list, then ACTH to localize | Rule out exogenous glucocorticoids first |
| Acute cholangitis or a duct stone | Right upper quadrant ultrasound | MRCP to diagnose; ERCP to diagnose and treat | ERCP is not the first test when the diagnosis is uncertain |
| Acute pancreatitis | Lipase | Contrast CT only if the diagnosis is unclear or the patient fails to improve after 48 to 72 hours | Pain plus lipase above 3 times normal is enough |
| Hepatocellular carcinoma | Ultrasound with or without AFP for surveillance | Multiphase CT or MRI | Arterial enhancement with washout is diagnostic without biopsy |
Clue in the stem, next best step
| Clue in the stem | What it points to | Next best step |
|---|---|---|
| Pleuritic chest pain, Wells low, otherwise well | Low-probability PE | D-dimer |
| Same patient with a Wells score that makes PE likely | High-probability PE | CT pulmonary angiography; skip D-dimer |
| Hypotension, distended neck veins, dilated right ventricle on bedside echo | High-risk PE | Systemic thrombolysis without waiting for CT |
| Fever and a new murmur 4 months after aortic valve replacement | Prosthetic valve endocarditis | Blood cultures and TEE |
| Platelets fall by 60% on day 7 of heparin, new leg DVT | Intermediate-to-high 4Ts score | Stop heparin, start a non-heparin anticoagulant, send the PF4 assay |
| Iron deficiency, diarrhea, low tTG-IgA with low total IgA | Celiac disease masked by IgA deficiency | Deamidated gliadin IgG, then duodenal biopsy |
| Hypertension, hypokalemia, undetectable renin, aldosterone 30 ng/dL | Primary aldosteronism without the need for confirmation | Adrenal CT |
| Episodic headache, sweating, palpitations | Possible pheochromocytoma | Plasma free metanephrines |
Where students lose points
- Ordering a D-dimer when the clinical probability of PE is already high. A negative result would not change the plan.
- Choosing CT of the adrenal glands before biochemical testing. Adrenal incidentalomas are common; the hormones decide whether the mass matters.
- Stopping at a negative TTE in a patient with a prosthetic valve or persistent bacteremia.
- Sending HIT antibodies when the 4Ts score is low.
- Testing for celiac disease after the patient has already gone gluten-free, or forgetting total IgA.
- Using H. pylori serology to confirm eradication.
- Taking an unstable patient to CT for a dissection or a PE when a bedside study would answer the question.
Practice question
A 54-year-old man is evaluated for hypertension that remains above target on lisinopril, amlodipine and chlorthalidone. He has muscle cramps. Blood pressure is 168/98 mm Hg. Serum potassium is 2.9 mEq/L before any potassium supplement, and serum bicarbonate is 31 mEq/L. Plasma aldosterone is 32 ng/dL, and plasma renin activity is below the detectable limit. Serum creatinine is normal.
Which of the following is the most appropriate next step?
- Oral sodium loading test
- CT of the adrenal glands
- Adrenal vein sampling
- Plasma free metanephrines
- Bilateral adrenalectomy
Show the answer
Answer: B. Spontaneous hypokalemia, renin below the detection limit and aldosterone above 20 ng/dL establish primary aldosteronism without a confirmatory suppression test (Endocrine Society 2016). The next step is adrenal CT to look for an adenoma, carcinoma or bilateral hyperplasia before deciding on lateralization testing.
Why the others are wrong. A: confirmatory testing adds nothing when the biochemistry is this clear. C: adrenal vein sampling comes after CT, in a patient who wants surgery, to show which side is producing aldosterone. D: nothing suggests pheochromocytoma. E: bilateral hyperplasia is treated medically with a mineralocorticoid receptor antagonist, not surgery.
60-second recall
Say each answer out loud before you reveal it, then mark yourself. Retrieval, not rereading, is what makes it stick.
1D-dimer
Rules out PE only when clinical probability is low or intermediate.Did you get it?2Suspected endocarditis with a prosthetic valve
Blood cultures and TEE.Did you get it?3HIT
4Ts score first; low score means no testing.Did you get it?4Celiac
tTG-IgA plus total IgA on gluten, then duodenal biopsy.Did you get it?5Adrenal disorders
Hormones first, imaging second.Did you get it?6Unstable patient
Bedside test (echocardiography or TEE), not the scanner.Did you get it?
Make retrieval a habit on every topic with Learning to Learn Medicine. Module 1 is free; the full bundle (the course plus all 12 Recall Labs) is a one-time $199.
Next: browse every Board Review post, review the GI algorithms for the medicine shelf, or see MedRise for students.
Sources
- Konstantinides SV, et al. 2019 ESC guidelines for the diagnosis and management of acute pulmonary embolism. Eur Heart J, 2020 (PubMed 31504429)
- Isselbacher EM, et al. 2022 ACC/AHA guideline for the diagnosis and management of aortic disease. Circulation, 2022 (PubMed 36322642)
- Fowler VG, et al. The 2023 Duke-International Society for Cardiovascular Infectious Diseases criteria for infective endocarditis. Clin Infect Dis, 2023 (PubMed 37138445)
- Delgado V, et al. 2023 ESC guidelines for the management of endocarditis. Eur Heart J, 2023 (PubMed 37622656)
- Cuker A, et al. American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia. Blood Adv, 2018 (PubMed 30482768)
- Rubio-Tapia A, et al. American College of Gastroenterology guidelines update: diagnosis and management of celiac disease. Am J Gastroenterol, 2023 (PubMed 36602836)
- Chey WD, et al. ACG clinical guideline: treatment of Helicobacter pylori infection. Am J Gastroenterol, 2024 (PubMed 39626064)
- Lenders JW, et al. Pheochromocytoma and paraganglioma: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab, 2014 (PubMed 24893135)
- Funder JW, et al. The management of primary aldosteronism: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab, 2016 (PubMed 26934393)
- Nieman LK, et al. The diagnosis of Cushing's syndrome: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab, 2008 (PubMed 18334580)
- Kiriyama S, et al. Tokyo Guidelines 2018: diagnostic criteria and severity grading of acute cholangitis. J Hepatobiliary Pancreat Sci, 2018 (PubMed 29032610)
- Tenner S, et al. American College of Gastroenterology guidelines: management of acute pancreatitis. Am J Gastroenterol, 2024 (PubMed 38857482)
- Singal AG, et al. AASLD practice guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma. Hepatology, 2023 (PubMed 37199193)
MedRise Board Review is educational content for exam preparation only. It is not medical advice and does not replace current guidelines, your school's materials or clinical judgment.



